What is the primary diagnosis and recommended management for a 72‑year‑old woman with a 17‑year history of hypertension on metoprolol (Neobloc) of unknown dose, presenting with severe uncontrolled hypertension and recent cataract surgery?

Primary Diagnosis and Management of Uncontrolled Hypertension in a 72-Year-Old Woman

Primary Diagnosis

The primary diagnosis is uncontrolled stage 2 hypertension (200/100 mmHg) on inadequate beta-blocker monotherapy, presenting as a perioperative hypertensive urgency requiring immediate optimization before elective cataract surgery.

This patient has severe blood pressure elevation that must be addressed before proceeding with any elective surgical intervention 1.

---

Immediate Preoperative Management

Blood Pressure Control Strategy

Do not proceed with elective cataract surgery until blood pressure is controlled to <180/110 mmHg, ideally <140/90 mmHg 1.

• Uncontrolled hypertension (≥180/110 mmHg) is associated with wider fluctuations during anesthesia induction and intubation, increasing perioperative ischemic event risk 1.
• For elective surgery, effective blood pressure control should be achieved over several days to weeks of outpatient treatment rather than rushing to surgery 1.
• The 2016 Anaesthesia guidelines explicitly state that blood pressure exceeding 180/110 mmHg should be controlled prior to elective procedures 1.

---

Pharmacologic Intensification (Stepwise Algorithm)

Step 1: Verify Current Beta-Blocker Regimen

Confirm the actual dose and adherence to metoprolol (Neobloc), as the patient cannot recall dosing 1, 2.

• Non-adherence accounts for approximately 50% of apparent treatment resistance and must be assessed first 1, 3, 2.
• If the patient is taking subtherapeutic doses (e.g., <100 mg daily), this alone may explain the poor control 4, 5.
• Beta-blockers are not preferred initial therapy for hypertension in this age group, but should be continued if already established 1.

Step 2: Add a Calcium Channel Blocker as Second Agent

Add amlodipine 5–10 mg once daily immediately to achieve guideline-recommended dual therapy 1, 6, 2.

• The combination of beta-blocker + calcium channel blocker provides complementary mechanisms (heart rate/contractility reduction + vasodilation) 6, 2.
• Amlodipine is safe in elderly patients and does not require dose adjustment for age 6.
• This combination is particularly appropriate given the patient's 17-year hypertension history and likely end-organ changes 1.
• Target blood pressure <140/90 mmHg minimum, ideally <130/80 mmHg for this high-risk patient 1, 6.

Step 3: Add a Thiazide-Like Diuretic if Dual Therapy Insufficient

If blood pressure remains ≥140/90 mmHg after 2–4 weeks on beta-blocker + amlodipine, add chlorthalidone 12.5–25 mg once daily 1, 6, 3.

• The triple combination of beta-blocker + calcium channel blocker + thiazide diuretic represents guideline-recommended therapy for resistant hypertension 1, 6.
• Chlorthalidone is preferred over hydrochlorothiazide due to superior 24-hour blood pressure control and cardiovascular outcome data 6, 3.
• Check serum potassium and creatinine 2–4 weeks after initiating the diuretic to detect hypokalemia or renal function changes 1, 6, 3.

Step 4: Consider Spironolactone for Resistant Hypertension

If blood pressure remains ≥140/90 mmHg despite optimized triple therapy, add spironolactone 25–50 mg daily as the preferred fourth-line agent 1, 6, 3.

• Spironolactone produces additional reductions of approximately 20–25 mmHg systolic and 10–12 mmHg diastolic when added to triple therapy 1, 6, 3.
• Monitor potassium closely (within 1–2 weeks) when combining spironolactone with beta-blockers, as hyperkalemia risk increases 1, 3.
• Only use spironolactone if serum potassium <4.5 mmol/L and eGFR >45 mL/min/1.73 m² 3.

---

Critical Preoperative Timeline

Urgent Optimization (2–4 Weeks)

• Week 1: Start amlodipine 5 mg daily; verify metoprolol adherence and dose 6, 2.
• Week 2: Recheck blood pressure; if still ≥140/90 mmHg, increase amlodipine to 10 mg and add chlorthalidone 12.5 mg 6, 3.
• Week 3–4: Recheck blood pressure and electrolytes; titrate chlorthalidone to 25 mg if needed 6, 3.
• Goal: Achieve blood pressure <140/90 mmHg before rescheduling cataract surgery 1.

Perioperative Medication Management

• Continue all antihypertensive medications until the time of surgery 1.
• Reinstate therapy as soon as possible postoperatively 1.
• Provide adequate potassium supplementation if needed to correct hypokalemia well in advance of surgery 1.

---

Evaluation for Secondary Hypertension

Screen for secondary causes given the severity of uncontrolled hypertension (200/100 mmHg) despite 17 years of treatment 1, 3.

Essential Screening Tests

• Serum sodium, potassium, creatinine, and estimated glomerular filtration rate 1, 3.
• Thyroid-stimulating hormone 3.
• Urinalysis for protein and sediment 1.
• Aldosterone-to-renin ratio to screen for primary aldosteronism (most common secondary cause) 1, 3.

Additional Considerations

• Obstructive sleep apnea screening (common in resistant hypertension) 1, 3.
• Renal artery stenosis evaluation if renal function is impaired or if there is an abdominal bruit 1, 3.
• Review for interfering medications: NSAIDs, decongestants, oral contraceptives, systemic corticosteroids 1, 6, 3.

---

Lifestyle Modifications (Adjunctive to Pharmacotherapy)

Implement comprehensive lifestyle changes to provide additive blood pressure reductions of 10–20 mmHg 1, 6, 2.

• Sodium restriction to <2 g/day yields 5–10 mmHg systolic reduction and enhances diuretic efficacy 1, 6, 3.
• DASH dietary pattern (high in fruits, vegetables, whole grains, low-fat dairy) reduces blood pressure by approximately 11.4/5.5 mmHg 1, 6.
• Weight loss if BMI ≥25 kg/m²—losing approximately 10 kg reduces blood pressure by ~6/4.6 mmHg 6, 2.
• Regular aerobic exercise (≥30 minutes most days, ≈150 minutes/week moderate intensity) lowers blood pressure by ~4/3 mmHg 1, 6.
• Alcohol limitation to ≤1 drink/day for women 1, 6.

---

Common Pitfalls to Avoid

Do Not Proceed with Surgery at Current Blood Pressure

• Elective surgery should be postponed until blood pressure is controlled to <180/110 mmHg, ideally <140/90 mmHg 1.
• Proceeding with surgery at 200/100 mmHg exposes the patient to unacceptable perioperative cardiovascular risk 1.

Do Not Rely on Beta-Blocker Monotherapy

• Beta-blockers are not preferred initial therapy for hypertension in elderly patients and are less effective than calcium channel blockers or diuretics for stroke prevention 1, 6, 3.
• Combination therapy is required for stage 2 hypertension (≥160/100 mmHg) 1, 6.

Do Not Delay Treatment Intensification

• Stage 2 hypertension (200/100 mmHg) requires prompt action within 2–4 weeks to reduce cardiovascular risk 1, 6, 3.
• Waiting months for gradual titration is inappropriate given the severity of elevation 1, 6.

Do Not Assume Treatment Failure Without Confirming Adherence

• Verify medication adherence through direct questioning, pill counts, or pharmacy refill records before escalating therapy 1, 6, 3, 2.
• The patient's inability to recall dosing suggests possible non-adherence or subtherapeutic dosing 1, 2.

Do Not Combine Beta-Blocker with ACE Inhibitor or ARB as Second Agent

• Add a calcium channel blocker or thiazide diuretic as the second agent, not an ACE inhibitor or ARB 1, 6.
• While ACE inhibitors/ARBs are appropriate third agents, calcium channel blockers and diuretics provide superior blood pressure reduction when added to beta-blockers 1, 6.

---

Monitoring and Follow-Up

Short-Term (2–4 Weeks)

• Recheck blood pressure after each medication adjustment 1, 6, 3.
• Monitor serum potassium and creatinine when diuretics are added 1, 6, 3.
• Assess for medication side effects (peripheral edema with amlodipine, electrolyte disturbances with diuretics) 6, 3.

Medium-Term (3 Months)

• Achieve target blood pressure <140/90 mmHg (minimum) or <130/80 mmHg (optimal) within 3 months of therapy modification 1, 6, 3.
• Complete secondary hypertension screening if blood pressure remains uncontrolled 1, 3.

Long-Term (6–12 Months)

• Monitor for hypertension-mediated organ damage: renal function, proteinuria, left ventricular hypertrophy 1, 3.
• Consider referral to hypertension specialist if blood pressure remains ≥140/90 mmHg despite four-drug therapy at optimal doses 1, 3.

---

Special Considerations for Cataract Surgery

Ophthalmologic Implications

• Hypertensive retinopathy may be present given 17-year hypertension history and current severe elevation 1.
• Fundoscopy should be performed to assess for hemorrhages, cotton wool spots, or papilledema 1.
• Severe hypertensive retinopathy may complicate cataract surgery outcomes and requires preoperative control 1.

Anesthetic Considerations

• Intraoperative hypertension is common and may require parenteral agents (sodium nitroprusside, nicardipine, labetalol) 1.
• Postoperative hypertension is very common and related to increased sympathetic tone; contributing factors include pain and increased intravascular volume 1.
• If oral medications must be interrupted postoperatively, consider periodic dosing with intravenous enalaprilat or transdermal clonidine 1.